Signet Jewelers, a jewellery retail giant whose brands include Kay Jewelers, Zales, Jared and Banter by Piercing Pagoda, announced a new $100 million commitment to St. Jude Children's Research Hospital®. Over the past 25 years, Signet has raised $100 million to support children with cancer and other life-threatening diseases, and this new $100 million commitment will further advance research and treatment.
Virginia C. Drosos, CEO of Signet Jewelers, said, “We are honoured to support the lifesaving research and care that St. Jude delivers to patients every single day. As a part of our core purpose, we are passionate about Inspiring Love through our products, team and in our community. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to more than 80% in the United States and we at Signet are so proud to have been a partner in the fight to increase survivorship.
“Our next $100 million commitment will help increase this even further and also go toward increasing survival rates around the world, where they are much lower. We won't stop fighting for a world in which no child dies in the dawn of life.”
Signet's additional $100 million dollar commitment will also support patients in thriving after surviving childhood cancer through ongoing research and care through the After Completion of Therapy Clinic and St. Jude LIFE Study Program. The St. Jude LIFE Study program is an unprecedented research study aimed at increasing survivorship and also helping cancer survivors to thrive.
“The longstanding commitment and amazing generosity of Signet, its employees and customers is a moving expression of love and an incredible testament to the company's purpose-driven culture,” said Richard C. Shadyac Jr., President and CEO of ALSAC, the fundraising and awareness organisation for St. Jude Children's Research Hospital.